CF
BVS icon

Corebridge Financial’s Bioventus BVS Stock Holding History

Corebridge Financial’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-18,783
Closed -$172K – 431
2025
Q1 		$172K Sell
18,783
-278
-1% -$2.78K ﹤0.01% 2159
2024
Q4 		$200K Sell
19,061
-1,012
-5% -$12K ﹤0.01% 2186
2024
Q3 		$240K Sell
20,073
-123
-0.6% -$1.06K ﹤0.01% 2127
2024
Q2 		$116K Buy
+20,196
New +$111K ﹤0.01% 2504

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Corebridge Financial's BVS Position: Q2 2025 in Review

Corebridge Financial sold out of Bioventus (BVS) in Q2 2025, closing a stake of 18,783 shares — an estimated $172K sold.

Corebridge Financial first reported a position in BVS in Q2 2024 and held it in 4 quarters. The position peaked at $240K in Q3 2024. 134 funds tracked by Wall St. Rank hold BVS as of Q2 2025.

  • Corebridge Financial reported no remaining Bioventus position as of Q2 2025 after selling out during the quarter.
  • Corebridge Financial sold 18,783 Bioventus shares in Q2 2025, an estimated $172K.
  • Corebridge Financial first reported a position in Bioventus in Q2 2024 and held it in 4 quarters.
  • Corebridge Financial's Bioventus position peaked at $240K in Q3 2024.
  • 134 funds tracked by Wall St. Rank held Bioventus as of Q2 2025.

Based on Corebridge Financial's 13F filing for Q2 2025, filed 12 Aug 2025.